Radiofrequency Ablation Devices Market Outlook 2031
The global radiofrequency ablation devices market size was valued at USD 4.30 Billion in 2022 and is likely reach to USD 11.83 Billion by 2031, expanding at a CAGR of 11.9% during the forecast period, between 2023 and 2031. Radiofrequency ablation devices are the approach utilized for medical operations, such as minimally invasive surgeries, which result in scarring, less pain, and rapid recovery for the patient.
The devices comprise a process in which the electrical conduction system of a heart, tumor or other tissues is ablated utilizing heat produced by alternating current at a medium frequency. Because of its ease of administration, high efficacy, and safety, it has become a preferred approach.
The radiofrequency current does not activate nerves and only treats a specific tissue without causing collateral damage. It is widely used in a variety of operations such as cardiology, gynecology, pain management, and others.
Market Trends, Drivers, Restraints, and Opportunities:
- Growing preference for minimally invasive surgeries, increasing healthcare spending for better disease treatment, and increasing senior population are expected to drive the market.
- Increased prevalence of chronic diseases such as arthritis and osteoporosis, as well as developing healthcare infrastructure, are driving the market.
- Advancement of various treatment approaches is boosting the market.
- Rising incidence of esophageal and gastric illnesses is the primary driver of the radiofrequency ablation device market.
- High treatment costs, availability of alternative treatments, and little awareness of the procedure hamper the market.
- Product innovations and technical advancements are creating significant growth opportunities for market players.
Scope of Radiofrequency Ablation Devices Market report:
The report on the radiofrequency ablation devices market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Radiofrequency Ablation Devices Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Products (Capital Equipment, Disposable Equipment, and Reusable Equipment), Applications (Cosmetology, Cardiology, [Irrigated Tip RF Ablation Catheters and Conventional RF Ablation Catheters], Cardiac Rhythm Management, Gynecology, Surgical Oncology, [Spinal Metastases, Prostate Cancer, Lung Cancer, Liver Cancer, Kidney Cancer, Colorectal Cancer, Breast Cancer, and Others], and Pain management [Knee Pain, Neck Pain, Shoulder Pain, Lower Back Pain, Upper Back Pain, and Other Pain Syndromes),
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
AtriCure, Inc.; St. Jude Medical, Inc.; Boston Scientific Corporation; Halyard Health, Inc.; Stryker Corporation; C. R. Bard, Inc.; Hologic, Inc.; AngioDynamics, Inc.; Medtronic Plc.; and Smith & Nephew
|
Radiofrequency Ablation Devices Market Segment Insights:
The disposable equipment segment is projected to hold significant market share
Based on products, the radiofrequency ablation devices market can be segregated into capital equipment, disposable equipment, and reusable equipment. The disposable equipment segment is projected to hold significant market share, due to advanced technology that can create vast regions of coagulate necrosis in a controlled manner, is generally less toxic, and has a low risk of consequences.
Furthermore, the connecting cords supplied with single-use probes are long enough to remain outside of the sterile region, preventing infection. It also enables a temperature-controlled lesion formation method. This increases demand for disposable products.
The surgical oncology segment is anticipated to account for a substantial share
On the basis of applications, the market can be fragmented into cosmetology, cardiology, cardiac rhythm management, gynecology, surgical oncology, and pain management. The cardiology segment can be further segmented into irrigated tip RF ablation catheters and conventional RF ablation catheters.
The surgical oncology segment can be further divided into spinal metastases, prostate cancer, lung cancer, liver cancer, kidney cancer, colorectal cancer, breast cancer, and others. The pain management segment can be segregated into knee pain, neck pain, shoulder pain, lower back pain, upper back pain, and other pain syndromes.
The surgical oncology segment is anticipated to account for a substantial share. Surgical oncology is gaining popularity as radiofrequency ablation can be utilized to treat cancerous cells in order to enhance the survival of high-risk patients with refractory malignancies and unresectable.
Radiofrequency Ablation Devices Market Regional Outlook
North America is expected to dominate the market
In terms of regions, the radiofrequency ablation devices market can be classified as Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is expected to dominate the market. The high frequency of cancer, great purchasing power, scientific innovations, and government backing for quality healthcare are all major elements leading to regional growth.
Segments
By Products
- Capital Equipment
- Disposable Equipment
- Reusable Equipment
By Applications
- Cosmetology
- Cardiology
- Irrigated Tip RF Ablation Catheters
- Conventional RF Ablation Catheters
- Cardiac Rhythm Management
- Gynaecology
- Surgical Oncology
- Spinal Metastases
- Prostate Cancer
- Lung Cancer
- Liver Cancer
- Kidney Cancer
- Colorectal Cancer
- Breast Cancer
- Other Cancers
- Pain management
- Knee Pain
- Neck Pain
- Shoulder Pain
- Lower Back Pain
- Upper Back Pain
- Other Pain Syndromes
By Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
By Key Players
Competitive Landscape
Key players in the radiofrequency ablation devices market include AtriCure, Inc.; St. Jude Medical, Inc.; Boston Scientific Corporation; Halyard Health, Inc.; Stryker Corporation; C. R. Bard, Inc.; Hologic, Inc.; AngioDynamics, Inc.; Medtronic Plc.; and Smith & Nephew.
These players have constantly engaged in several market development strategies including collaborations, agreements, mergers & acquisitions, production capacity expansion, new product launches, and partnerships to increase their market share.
Request For Customization
Enquiry Before Buying
Speak With Analyst
